Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
Go back to Ligand Reports Fourth Quarter and Full Year 2021 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 283.49 -1.21 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $284.70 | 52 Week High | $139.79 | |||
| Open | $285.63 | 52 Week Low | $82.07 | |||
| Day High | $285.64 | P/E | 659.28 | |||
| Day Low | $280.49 | EPS | $0.43 | |||
| Volume | 372,802 | |||||
| (NASDAQ: VRNA) | Delayed: 106.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.91 | 52 Week High | $ | |||
| Open | $106.91 | 52 Week Low | $ | |||
| Day High | $106.91 | P/E | N/A | |||
| Day Low | $106.91 | EPS | $ | |||
| Volume | 864,095 | |||||
